10.1002/oby.20584 3 BabuN.BhattD
Those that do cover them typically do so through their medical benefit, offering GLP-1s through a rebate negotiated by their pharmacy benefit manager (PBM), she said
According to the American Diabetes Association , studies comparing GLP-1 medications have demonstrated significant weight loss potential for both semaglutide and tirzepatide
Theres a major gap in the GLP-1 literature where we dont know how midlife women in general respond to these drugs, she says
What has happened over time is that as these legislations have passed, weve paid little attention as a community of patients, providers, pharma companies, employers, on how those regulations have been written
While these drugs have been praised for their ability to help people drop weight quickly, it is important to understand the potential risks associated with this rapid weight loss and the ways to mitigate risks with regular body composition scans during treatment